This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Demoulin, J. B.
Right arrow Articles by Renauld, J. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Demoulin, J. B.
Right arrow Articles by Renauld, J. C.

 Previous Article  |  Next Article 

Mol. Cell. Biol., 09 1996, 4710-4716, Vol 16, No. 9
Copyright © 1996, American Society for Microbiology

A single tyrosine of the interleukin-9 (IL-9) receptor is required for STAT activation, antiapoptotic activity, and growth regulation by IL-9

JB Demoulin, C Uyttenhove, E Van Roost, B DeLestre, D Donckers, J Van Snick and JC Renauld
Brussels Branch, Ludwig Institute for Cancer Research, Brussels, Belgium.

Interleukin-9 (IL-9), a T-cell-derived cytokine, interacts with a specific receptor associated with the IL-2 receptor gamma chain. In this report, we analyze the functional domains of the human IL-9 receptor transfected into mouse lymphoid cell lines. Three different functions were examined: growth stimulation in factor-dependent pro-B Ba/F3 cells, protection against dexamethasone-induced apoptosis, and Ly- 6A2 induction in BW5147 lymphoma cells. The results indicated that a single tyrosine, at position 116 in the cytoplasmic domain, was required for all three activities. In addition, we observed that human IL-9 reduced the proliferation rate of transfected BW5147 cells, an effect also dependent on the same tyrosine. This amino acid was necessary for IL-9-mediated tyrosine phosphorylation of the receptor and for STAT activation but not for IRS-2/4PS activation or for JAK1 phosphorylation, which depended on a domain closer to the plasma membrane. We also showed that JAK1 was constitutively associated with the IL-9 receptor. Activated STAT complexes induced by IL-9 were found to contain STAT1, STAT3, and STAT5 transcription factors. Moreover, sequence homologies between human IL-9 receptor tyrosine 116 and tyrosines (of other receptors activating STAT3 and STAT5 were observed. Taken together, these data indicate that a single tyrosine of the IL-9 receptor, required for activation of three different STAT proteins, is necessary for distinct activities of this cytokine, including proliferative responses.


This article has been cited by other articles:

  • Dumoutier, L., de Meester, C., Tavernier, J., Renauld, J.-C. (2009). New Activation Modus of STAT3: A TYROSINE-LESS REGION OF THE INTERLEUKIN-22 RECEPTOR RECRUITS STAT3 BY INTERACTING WITH ITS COILED-COIL DOMAIN. J. Biol. Chem. 284: 26377-26384 [Abstract] [Full Text]  
  • Elyaman, W., Bradshaw, E. M., Uyttenhove, C., Dardalhon, V., Awasthi, A., Imitola, J., Bettelli, E., Oukka, M., van Snick, J., Renauld, J.-C., Kuchroo, V. K., Khoury, S. J. (2009). IL-9 induces differentiation of TH17 cells and enhances function of FoxP3+ natural regulatory T cells. Proc. Natl. Acad. Sci. USA 106: 12885-12890 [Abstract] [Full Text]  
  • Toffalini, F., Kallin, A., Vandenberghe, P., Pierre, P., Michaux, L., Cools, J., Demoulin, J.-B. (2009). The fusion proteins TEL-PDGFR{beta} and FIP1L1-PDGFR{alpha} escape ubiquitination and degradation. haematol 94: 1085-1093 [Abstract] [Full Text]  
  • Essaghir, A., Dif, N., Marbehant, C. Y., Coffer, P. J., Demoulin, J.-B. (2009). The Transcription of FOXO Genes Is Stimulated by FOXO3 and Repressed by Growth Factors. J. Biol. Chem. 284: 10334-10342 [Abstract] [Full Text]  
  • Hornakova, T., Staerk, J., Royer, Y., Flex, E., Tartaglia, M., Constantinescu, S. N., Knoops, L., Renauld, J.-C. (2009). Acute Lymphoblastic Leukemia-associated JAK1 Mutants Activate the Janus Kinase/STAT Pathway via Interleukin-9 Receptor {alpha} Homodimers. J. Biol. Chem. 284: 6773-6781 [Abstract] [Full Text]  
  • Flex, E., Petrangeli, V., Stella, L., Chiaretti, S., Hornakova, T., Knoops, L., Ariola, C., Fodale, V., Clappier, E., Paoloni, F., Martinelli, S., Fragale, A., Sanchez, M., Tavolaro, S., Messina, M., Cazzaniga, G., Camera, A., Pizzolo, G., Tornesello, A., Vignetti, M., Battistini, A., Cave, H., Gelb, B. D., Renauld, J.-C., Biondi, A., Constantinescu, S. N., Foa, R., Tartaglia, M. (2008). Somatically acquired JAK1 mutations in adult acute lymphoblastic leukemia. JEM 205: 751-758 [Abstract] [Full Text]  
  • Freund, C., Schmidt-Ullrich, R., Baurand, A., Dunger, S., Schneider, W., Loser, P., El-Jamali, A., Dietz, R., Scheidereit, C., Bergmann, M. W. (2005). Requirement of Nuclear Factor-{kappa}B in Angiotensin II- and Isoproterenol-Induced Cardiac Hypertrophy In Vivo. Circulation 111: 2319-2325 [Abstract] [Full Text]  
  • Melen, E, Gullsten, H, Zucchelli, M, Lindstedt, A, Nyberg, F, Wickman, M, Pershagen, G, Kere, J (2004). Sex specific protective effects of interleukin-9 receptor haplotypes on childhood wheezing and sensitisation. J. Med. Genet. 41: e123-e123 [Full Text]  
  • Gounni, A. S., Hamid, Q., Rahman, S. M., Hoeck, J., Yang, J., Shan, L. (2004). IL-9-Mediated Induction of Eotaxin1/CCL11 in Human Airway Smooth Muscle Cells. J. Immunol. 173: 2771-2779 [Abstract] [Full Text]  
  • Dumoutier, L., Tounsi, A., Michiels, T., Sommereyns, C., Kotenko, S. V., Renauld, J.-C. (2004). Role of the Interleukin (IL)-28 Receptor Tyrosine Residues for Antiviral and Antiproliferative Activity of IL-29/Interferon-{lambda}1: SIMILARITIES WITH TYPE I INTERFERON SIGNALING. J. Biol. Chem. 279: 32269-32274 [Abstract] [Full Text]  
  • Hartman, M. E., O'Connor, J. C., Godbout, J. P., Minor, K. D., Mazzocco, V. R., Freund, G. G. (2004). Insulin Receptor Substrate-2-dependent Interleukin-4 Signaling in Macrophages Is Impaired in Two Models of Type 2 Diabetes Mellitus. J. Biol. Chem. 279: 28045-28050 [Abstract] [Full Text]  
  • Shelburne, C. P., McCoy, M. E., Piekorz, R., Sexl, V., Roh, K.-H., Jacobs-Helber, S. M., Gillespie, S. R., Bailey, D. P., Mirmonsef, P., Mann, M. N., Kashyap, M., Wright, H. V., Chong, H. J., Bouton, L. A., Barnstein, B., Ramirez, C. D., Bunting, K. D., Sawyer, S., Lantz, C. S., Ryan, J. J. (2003). Stat5 expression is critical for mast cell development and survival. Blood 102: 1290-1297 [Abstract] [Full Text]  
  • Wiederkehr-Adam, M., Ernst, P., Muller, K., Bieck, E., Gombert, F. O., Ottl, J., Graff, P., Grossmuller, F., Heim, M. H. (2003). Characterization of Phosphopeptide Motifs Specific for the Src Homology 2 Domains of Signal Transducer and Activator of Transcription 1 (STAT1) and STAT3. J. Biol. Chem. 278: 16117-16128 [Abstract] [Full Text]  
  • Xiao, H., Chung, J., Kao, H.-Y., Yang, Y.-C. (2003). Tip60 Is a Co-repressor for STAT3. J. Biol. Chem. 278: 11197-11204 [Abstract] [Full Text]  
  • Pilette, C., Ouadrhiri, Y., Van Snick, J., Renauld, J.-C., Staquet, P., Vaerman, J.-P., Sibille, Y. (2002). IL-9 Inhibits Oxidative Burst and TNF-{alpha} Release in Lipopolysaccharide-Stimulated Human Monocytes Through TGF-{beta}. J. Immunol. 168: 4103-4111 [Abstract] [Full Text]  
  • Xiao, H., Yin, T., Wang, X.-Y., Uchida, T., Chung, J., White, M. F., Yang, Y.-C. (2002). Specificity of Interleukin-2 Receptor gamma Chain Superfamily Cytokines Is Mediated by Insulin Receptor Substrate-dependent Pathway. J. Biol. Chem. 277: 8091-8098 [Abstract] [Full Text]  
  • Woldman, I., Varinou, L., Ramsauer, K., Rapp, B., Decker, T. (2001). The Stat1 Binding Motif of the Interferon-gamma Receptor Is Sufficient to Mediate Stat5 Activation and Its Repression by SOCS3. J. Biol. Chem. 276: 45722-45728 [Abstract] [Full Text]  
  • Dumoutier, L., Leemans, C., Lejeune, D., Kotenko, S. V., Renauld, J.-C. (2001). Cutting Edge: STAT Activation By IL-19, IL-20 and mda-7 Through IL-20 Receptor Complexes of Two Types. J. Immunol. 167: 3545-3549 [Abstract] [Full Text]  
  • Demoulin, J.-B., Van Snick, J., Renauld, J.-C. (2001). Interleukin-9 (IL-9) Induces Cell Growth Arrest Associated with Sustained Signal Transducer and Activator of Transcription Activation in Lymphoma Cells Overexpressing the IL-9 Receptor. Cell Growth Differ. 12: 169-174 [Abstract] [Full Text]  
  • Demoulin, J.-B., Uyttenhove, C., Lejeune, D., Mui, A., Groner, B., Renauld, J.-C. (2000). STAT5 Activation Is Required for Interleukin-9-dependent Growth and Transformation of Lymphoid Cells. Cancer Res. 60: 3971-3977 [Abstract] [Full Text]  
  • De Smedt, M., Verhasselt, B., Kerre, T., Vanhecke, D., Naessens, E., Leclercq, G., Renauld, J.-C., Van Snick, J., Plum, J. (2000). Signals from the IL-9 Receptor Are Critical for the Early Stages of Human Intrathymic T Cell Development. J. Immunol. 164: 1761-1767 [Abstract] [Full Text]  
  • Dumoutier, L., Louahed, J., Renauld, J.-C. (2000). Cloning and Characterization of IL-10-Related T Cell-Derived Inducible Factor (IL-TIF), a Novel Cytokine Structurally Related to IL-10 and Inducible by IL-9. J. Immunol. 164: 1814-1819 [Abstract] [Full Text]  
  • Lahuna, O., Rastegar, M., Maiter, D., Thissen, J.-P., Lemaigre, F. P., Rousseau, G. G. (2000). Involvement of STAT5 (Signal Transducer and Activator of Transcription 5) and HNF-4 (Hepatocyte Nuclear Factor 4) in the Transcriptional Control of the hnf6 Gene by Growth Hormone. Mol. Endocrinol. 14: 285-294 [Abstract] [Full Text]  
  • Uckun, F. M., Ek, O., Liu, X.-P., Chen, C.-L. (1999). In Vivo Toxicity and Pharmacokinetic Features of the Janus Kinase 3 Inhibitor WHI-P131 [4-(4'Hydroxyphenyl)-Amino-6,7-Dimethoxyquinazoline]. Clin. Cancer Res. 5: 2954-2962 [Abstract] [Full Text]  
  • Demoulin, J.-B., Van Roost, E., Stevens, M., Groner, B., Renauld, J.-C. (1999). Distinct Roles for STAT1, STAT3, and STAT5 in Differentiation Gene Induction and Apoptosis Inhibition by Interleukin-9. J. Biol. Chem. 274: 25855-25861 [Abstract] [Full Text]  
  • Louahed, J., Grasso, L., De Smet, C., Van Roost, E., Wildmann, C., Nicolaides, N. C., Levitt, R. C., Renauld, J.-C. (1999). Interleukin-9-Induced Expression of M-Ras/R-Ras3 Oncogene in T-Helper Clones. Blood 94: 1701-1710 [Abstract] [Full Text]  
  • Friedrich, K., Kammer, W., Erhardt, I., Brandlein, S., Sebald, W., Moriggl, R. (1999). Activation of STAT5 by IL-4 relies on Janus kinase function but not on receptor tyrosine phosphorylation, and can contribute to both cell proliferation and gene regulation. Int Immunol 11: 1283-1294 [Abstract] [Full Text]  
  • Richard, M., Louahed, J., Demoulin, J.-B., Renauld, J.-C. (1999). Interleukin-9 Regulates NF-kappa B Activity Through BCL3 Gene Induction. Blood 93: 4318-4327 [Abstract] [Full Text]  
  • Sudbeck, E. A., Liu, X.-P., Narla, R. K., Mahajan, S., Ghosh, S., Mao, C., Uckun, F. M. (1999). Structure-based Design of Specific Inhibitors of Janus Kinase 3 as Apoptosis-inducing Antileukemic Agents. Clin. Cancer Res. 5: 1569-1582 [Abstract] [Full Text]  
  • Lischke, A., Moriggl, R., Brandlein, S., Berchtold, S., Kammer, W., Sebald, W., Groner, B., Liu, X., Hennighausen, L., Friedrich, K. (1998). The Interleukin-4 Receptor Activates STAT5 by a Mechanism That Relies upon Common gamma -Chain. J. Biol. Chem. 273: 31222-31229 [Abstract] [Full Text]  
  • Sun, H. B., Zhu, Y. X., Yin, T., Sledge, G., Yang, Y.-C. (1998). MRG1, the product of a melanocyte-specific gene related gene, is a cytokine-inducible transcription factor with transformation activity. Proc. Natl. Acad. Sci. USA 95: 13555-13560 [Abstract] [Full Text]  
  • Grasso, L., Huang, M., Sullivan, C. D., Messler, C. J., Kiser, M. B., Dragwa, C. R., Holroyd, K. J., Renauld, J.-C., Levitt, R. C., Nicolaides, N. C. (1998). Molecular Analysis of Human Interleukin-9 Receptor Transcripts in Peripheral Blood Mononuclear Cells. IDENTIFICATION OF A SPLICE VARIANT ENCODING FOR A NONFUNCTIONAL CELL SURFACE RECEPTOR. J. Biol. Chem. 273: 24016-24024 [Abstract] [Full Text]  
  • Goodman, P. A., Niehoff, L. B., Uckun, F. M. (1998). Role of Tyrosine Kinases in Induction of the c-jun Proto-oncogene in Irradiated B-lineage Lymphoid Cells. J. Biol. Chem. 273: 17742-17748 [Abstract] [Full Text]  
  • Bauer, J. H., Liu, K. D., You, Y., Lai, S. Y., Goldsmith, M. A. (1998). Heteromerization of the gamma c Chain with the Interleukin-9 Receptor alpha  Subunit Leads to STAT Activation and Prevention of Apoptosis. J. Biol. Chem. 273: 9255-9260 [Abstract] [Full Text]  
  • Zhu, Y. X., Sun, H. B., Tsang, M. L.-S., McMahel, J., Grigsby, S., Yin, T., Yang, Y.-C. (1997). Critical Cytoplasmic Domains of Human Interleukin-9 Receptor alpha  Chain in Interleukin-9-mediated Cell Proliferation and Signal Transduction. J. Biol. Chem. 272: 21334-21340 [Abstract] [Full Text]  
  • Kirken, R. A., Malabarba, M. G., Xu, J., DaSilva, L., Erwin, R. A., Liu, X., Hennighausen, L., Rui, H., Farrar, W. L. (1997). Two Discrete Regions of Interleukin-2 (IL2) Receptor beta  Independently Mediate IL2 Activation of a PD98059/Rapamycin/Wortmannin-insensitive Stat5a/b Serine Kinase. J. Biol. Chem. 272: 15459-15465 [Abstract] [Full Text]  
  • Dumoutier, L., Van Roost, E., Colau, D., Renauld, J.-C. (2000). Human interleukin-10-related T cell-derived inducible factor: Molecular cloning and functional characterization as an hepatocyte-stimulating factor. Proc. Natl. Acad. Sci. USA 97: 10144-10149 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»